{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-057938","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2026-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.820832+00:00","generated_at":"2026-05-14T19:28:58.710815+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Quest Diagnostics issues $500M of 5.000% senior notes due 2036","bullets":["$500M aggregate principal, 5.000% coupon, maturity June 30, 2036.","Interest payable semi-annually on June 30 and Dec 30, beginning Dec 30, 2026.","Senior unsecured, ranks equally with existing senior debt; no sinking fund.","Upon a change of control triggering event, repurchase at 101% plus accrued interest.","Issued under existing indenture as supplemented by twenty-fourth supplemental indenture."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-057938","json":"https://secwatch.observer/filing/0001104659-26-057938.json","markdown":"https://secwatch.observer/filing/0001104659-26-057938.md","text":"https://secwatch.observer/filing/0001104659-26-057938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/tm2613096d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T19:28:58.710815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d1f6423341a45356318fa5be7b38a05f8d320be1","claim":"QUEST DIAGNOSTICS INC entered into Indenture with The Bank of New York Mellon valued at $500,000,000 aggregate principal amount (effective 2026-05-06).","evidence_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001193125-26-251718","ticker":"PFLT","company_name":"PennantPark Floating Rate Capital Ltd.","filed_at":"2026-06-01T21:09:48+00:00","headline":"PennantPark Floating Rate Capital issues $105M 7.375% Notes due 2031","event_type":"debt","sec_items":["1.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: debt","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251718","json":"https://secwatch.observer/filing/0001193125-26-251718.json","markdown":"https://secwatch.observer/filing/0001193125-26-251718.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1504619/000119312526251718/0001193125-26-251718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1504619/000119312526251718/d37162d8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","comparable_excerpt":"On June 1, 2026, PennantPark Floating Rate Capital Ltd. (the “Company”) and Equiniti Trust Company, LLC (the “Trustee”) entered into a Third Supplemental Indenture (the “Third Supplemental Indenture”) to the Indenture between the Company and the Trustee, dated March 23, 2021 (the “Base Indenture,” and together with the Third Supplemental Indenture, the “Indenture”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1504619/000119312526251718/0001193125-26-251718-index.htm"}},{"accession":"0001140361-26-023577","ticker":"TCPC","company_name":"BlackRock TCP Capital Corp.","filed_at":"2026-06-01T20:50:02+00:00","headline":"BlackRock TCP Capital closes $535.8M CLO securitization, repays existing debt facilities","event_type":"debt","sec_items":["1.01","1.02","2.03","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: debt","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-023577","json":"https://secwatch.observer/filing/0001140361-26-023577.json","markdown":"https://secwatch.observer/filing/0001140361-26-023577.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370755/000114036126023577/0001140361-26-023577-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370755/000114036126023577/ef20075169_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","comparable_excerpt":"On the Closing Date, TCPC II entered into a payoff letter (“ Payoff Letter ”) to terminate the Loan and Servicing Agreement dated as of August 4, 2020 (as amended, modified, supplemented, restated or replaced from time to time, the “ LSA ”) among TCPC II, as borrower, Special Value Continuation Partners LLC, as servicer, Morgan Stanley Asset Funding Inc., as administrative agent and Morgan Stanley Bank, N.A., City National Bank, as lenders and Wells Fargo Bank, National Association, as the collateral agent, the account bank and the collateral custodian.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1370755/000114036126023577/0001140361-26-023577-index.htm"}},{"accession":"0001967680-26-000034","ticker":"VLTO","company_name":"Veralto Corp","filed_at":"2026-06-01T20:48:48+00:00","headline":"Veralto issues $725M of 4.850% Senior Notes due 2032, net proceeds ~$718.8M","event_type":"debt","sec_items":["1.01","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: debt","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001967680-26-000034","json":"https://secwatch.observer/filing/0001967680-26-000034.json","markdown":"https://secwatch.observer/filing/0001967680-26-000034.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1967680/000196768026000034/0001967680-26-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1967680/000196768026000034/vlto-20260527.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","comparable_excerpt":"On June 1, 2026, Veralto Corporation (the “Company”) issued $725,000,000 aggregate principal amount of 4.850% Senior Notes due 2032 (the “Notes”) in an underwritten offering (the “Offering”) pursuant to a registration statement on Form S-3ASR (File No. 333-282816) filed with the Securities and Exchange Commission (the “Commission”) on October 24, 2024 (the “Registration Statement”) and a preliminary prospectus supplement and prospectus supplement filed with the Commission related to the Offering. The Notes were issued under an indenture, dated as of June 1, 2026 (the “Base Indenture”) and the First Supplemental Indenture, dated as of June 1, 2026 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), between the Company, as issuer, and Deutsche Bank Trust Company Americas, as trustee.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1967680/000196768026000034/0001967680-26-000034-index.htm"}},{"accession":"0001193125-26-251551","ticker":"BFAM","company_name":"BRIGHT HORIZONS FAMILY SOLUTIONS INC.","filed_at":"2026-06-01T20:31:06+00:00","headline":"Bright Horizons secures $375M term loan, ups revolver to $1B with 2030 maturity","event_type":"debt","sec_items":["1.01","2.03","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: debt","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251551","json":"https://secwatch.observer/filing/0001193125-26-251551.json","markdown":"https://secwatch.observer/filing/0001193125-26-251551.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1437578/000119312526251551/0001193125-26-251551-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1437578/000119312526251551/d139662d8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","comparable_excerpt":"On June 1, 2026 (the “ Closing Date ”), Bright Horizons Family Solutions LLC (the “ Borrower ”), a wholly-owned indirect subsidiary of Bright Horizons Family Solutions Inc. (the “ Company ”), entered into the Fifth Amendment to Second Amended and Restated Credit Agreement","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1437578/000119312526251551/0001193125-26-251551-index.htm"}},{"accession":"0000785161-26-000161","ticker":"EHC","company_name":"Encompass Health Corp","filed_at":"2026-06-01T20:26:16+00:00","headline":"Encompass Health issues $500M 5.875% notes due 2034; to redeem $400M of 4.500% notes due 2028","event_type":"debt","sec_items":["1.01","2.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: debt","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000785161-26-000161","json":"https://secwatch.observer/filing/0000785161-26-000161.json","markdown":"https://secwatch.observer/filing/0000785161-26-000161.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000161/0000785161-26-000161-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000161/ehc-20260529.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","comparable_excerpt":"On May 29, 2026, Encompass Health Corporation (the \"Company\") completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the \"Notes\"), along with the related guarantees of the Notes by certain of the Company's subsidiaries (the \"Guarantees\"), in a private offering.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000161/0000785161-26-000161-index.htm"}},{"accession":"0001104659-26-068908","ticker":"PFG","company_name":"PRINCIPAL FINANCIAL GROUP INC","filed_at":"2026-06-01T20:05:54+00:00","headline":"Principal Financial Group issues $400M of 5.300% Senior Notes due 2037","event_type":"debt","sec_items":["1.01","2.03","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: debt","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068908","json":"https://secwatch.observer/filing/0001104659-26-068908.json","markdown":"https://secwatch.observer/filing/0001104659-26-068908.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1126328/000110465926068908/0001104659-26-068908-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1126328/000110465926068908/tm2614965d5_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","comparable_excerpt":"On June 1, 2026, Principal Financial Group, Inc. (the “Company”) issued $400,000,000 aggregate principal amount of its 5.300% Senior Notes due 2037 (the “Notes”). The Notes were issued pursuant to the Senior Indenture, dated as of May 21, 2009 (the “Senior Indenture”), among the Company, as issuer, Principal Financial Services, Inc. (“PFSI”), as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee, as supplemented by the Eighteenth Supplemental Indenture, dated as of June 1, 2026 (the “Supplemental Indenture”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1126328/000110465926068908/0001104659-26-068908-index.htm"}},{"accession":"0000932696-26-000063","ticker":"NSIT","company_name":"INSIGHT ENTERPRISES INC","filed_at":"2026-06-01T17:36:39+00:00","headline":"Insight Enterprises adds $100M swingline sub-facility via seventh amendment to ABL credit agreement","event_type":"debt","sec_items":["1.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: debt","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000932696-26-000063","json":"https://secwatch.observer/filing/0000932696-26-000063.json","markdown":"https://secwatch.observer/filing/0000932696-26-000063.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/932696/000093269626000063/0000932696-26-000063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/932696/000093269626000063/nsit-20260528.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","comparable_excerpt":"On May 28, 2026, Insight Enterprises, Inc. (“Insight”) entered into a seventh amendment to credit agreement (the “Seventh Amendment”) with JPMorgan Chase Bank, N.A., as Administrative Agent (the “Agent”), the lenders party thereto, certain of Insight’s subsidiaries organized in the United States, the United Kingdom, the Netherlands and Australia, as additional borrowers (collectively with Insight, the “Borrowers”), and certain of Insight’s subsidiaries organized in the United States, the United Kingdom, the Netherlands, Australia and Canada, as guarantors (collectively, the “Guarantors”), which amends the credit agreement, dated as of August 30, 2019 (as amended the “ABL Credit Agreement”)","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/932696/000093269626000063/0000932696-26-000063-index.htm"}},{"accession":"0001193125-26-214205","ticker":"PGIM","company_name":"PGIM Private Credit Fund","filed_at":"2026-05-08T23:59:59+00:00","headline":"PGIM Private Credit Fund enters $100M credit facility with $500M accordion option","event_type":"debt","sec_items":["1.01","2.03","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 9.01","same event type: debt","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-214205","json":"https://secwatch.observer/filing/0001193125-26-214205.json","markdown":"https://secwatch.observer/filing/0001193125-26-214205.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1923622/000119312526214205/0001193125-26-214205-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1923622/000119312526214205/ck0001923622-20260505.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000110465926057938/0001104659-26-057938-index.htm","comparable_excerpt":"On May 5, 2026 (the \"Closing Date\"), PGIM Private Credit Fund ABL LLC (the \"SPV\"), a wholly owned subsidiary of PGIM Private Credit Fund (the \"Fund\"), entered into a loan financing and servicing agreement (the \"Credit Facility\") with Deutsche Bank AG, New York Branch, as facility agent, and State Street Bank and Trust Company, as collateral agent and collateral custodian, the Fund, as equityholder and servicer, the SPV, as borrower, and the lenders from time to time party thereto","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1923622/000119312526214205/0001193125-26-214205-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}